Immatics NV (IMTX)
10.94
+0.13
(+1.20%)
USD |
NASDAQ |
May 17, 16:00
10.94
0.00 (0.00%)
After-Hours: 20:00
Immatics Accounts Receivable (Quarterly): 1.923M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.923M |
| December 31, 2023 | 4.524M |
| September 30, 2023 | 0.5441M |
| June 30, 2023 | 0.3586M |
| March 31, 2023 | 0.2519M |
| December 31, 2022 | 1.191M |
| September 30, 2022 | 1.120M |
| June 30, 2022 | 1.004M |
| March 31, 2022 | 0.8282M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.7722M |
| September 30, 2021 | 0.8409M |
| June 30, 2021 | 0.8544M |
| March 31, 2021 | 0.6741M |
| December 31, 2020 | 1.537M |
| September 30, 2020 | 1.232M |
| June 30, 2020 | 0.4802M |
| December 31, 2019 | 1.072M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.2519M
Minimum
Mar 2023
4.524M
Maximum
Dec 2023
1.130M
Average
0.8544M
Median
Jun 2021
Accounts Receivable (Quarterly) Benchmarks
| MorphoSys AG | 35.48M |
| Affimed NV | 5.888M |
| InflaRx NV | 0.0381M |
| BioNTech SE | 1.771B |
| CureVac NV | 15.84M |